Campaigner Jayne on her legacy and life after cancer WalesOnline, United Kingdom - WHEN women in Wales are diagnosed with the most aggressive form of breast cancer, they are offered a potentially life-changing drug. ...
Survey focuses on needs of breast cancer survivors Anchorage Daily News, AK - Nov 29, 2008 The requirements to be part of the survey are that breast cancer survivors are over 18 and live in Alaska. They must also be female. "We're basically trying ...
Health insurance sticker shock hits consumers Chicago Tribune, United States - She?s had two pulmonary embolisms and breast cancer but works full time in a junior high cafeteria to help pay the bills. Trznadel contacted me earlier this ...
The emotional side of breast cancer and its treatments Gather.com, MA - Throughout, the book relies on solid, timely research and new ways of thinking that can change the lives of breast cancer survivors for the better.
Genomic Health Announces Second Quarter 2008 Financial Results and ... eMediaWorld.com Newswire Press Release Distribution Service (press release), AZ - 46 minutes ago Product revenue from the Oncotype DX(R) breast cancer assay was $26.3 million in the second quarter of 2008, an increase of 81 percent compared to $14.6 ...GHDX
Breast self-exams don't save lives, new study says Press of Atlantic City, NJ - Aug 4, 2008 As the evidence mounted five years ago, the American Cancer Society quietly stopped recommending that all women do monthly breast self-exams. ...
Cancer registry releases county review Mt. Vernon Register-News, IL - Breast cancer was also a cancer reported in higher numbers throughout the state. In Southern Illinois: Clinton County 111; Effingham County at 131; ...
Friends walking for a cure Spartanburg Herald Journal (subscription), SC - Find info about the '"Breast Cancer 3-Day" at www.the3day.org. She was diagnosed three years ago at age 35. She wasn't planning to have her first mammogram ...
Diet and exercise can help prevent recurrence of cancer Reading Eagle, PA - By F?lix Alfonso Pe?a Bern Township, PA - For Karen L. Colon, learning how diet and exercise can help protect her from a recurrence of breast cancer gave ...
Health Front and Center Publishers Weekly, NY - So, potentially, the book speaks to those with a diagnosis, those whose lives cancer has touched, those concerned about it and those interested in ...
Quality of life in breast cancer: Part II: Psychological and spiritual well-being. - BR Ferrell, M Grant, DN Sc, B Funk, S Otis-Green, … - Cancer Nursing, 1998 - cancernursingonline.com ... Table 7. As with our similar survivorship studies, the breastcancer survivors
described how dramatically their lives had been altered as a result of cancer. ...
Risk of Breast Cancer and Organochlorine Exposure - MS Wolff, A Zeleniuch-Jacquotte, N Dubin, P … - Cancer Epidemiology Biomarkers & Prevention, 2000 - AACR ... of breastcancer risk with DDE or PCB levels in blood (based on samples collected
during the period 1987?1992) nor with their elimination half-lives. ...
Quality of life in breast cancer: Part I: Physical and social well-being. - BR Ferrell, M Grant, DN Sc, B Funk, S Otis-Green, … - Cancer Nursing, 1997 - cancernursingonline.com ...breastcancer. Women, even many years after diagnosis, described the continued
demands of breastcancer on their lives. The physical ...
Breast cancer survivors: Psychosocial concerns and quality of life - PA Ganz, A Coscarelli, C Fred, B Kahn, ML Polinsky … - Breast Cancer Research and Treatment, 1996 - Springer ... were as follows: 'In what ways, if any, has hav- ing had breastcancer 1) changed ...
your views of yourself, 4) changed your view of the world we live in.' Cate ...
Learn, Share, and Live: Breast Cancer Education for Older, Urban Minority Women - CS Skinner, RK Sykes, BS Monsees, DA Andriole, CL … - Health Education & Behavior, 1998 - heb.sagepub.com ... Page 2. Learn, Share, and Live: BreastCancer... among their peers. Learn, Share, and Live seems to be an effective program for promoting breastcancer...
Source: Google Scholar
Breast cancer pill saves few lives, study finds
WASHINGTON - Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives, U.S. researchers reported on Monday.
Women at the highest risk of breast cancer do appear to live longer if they take tamoxifen, the researchers report in the latest issue of the journal Cancer.But for women at the low end of the high-risk group, the sometimes serious side effects of tamoxifen outweigh the benefits, Dr. Joy Melnikow of the University of California, Davis, and colleagues reported.Tamoxifen can cause blood clots and uterine cancer."We found that for women at the lower end of the high-risk range for developing breast cancer, there is a very small likelihood that taking tamoxifen will reduce mortality," Melnikow said in a statement.Melnikow and her colleagues calculated that tamoxifen can extend life expectancy only when a woman's five-year risk of developing breast cancer is 3 percent or higher. This is especially true for women who have not had a hysterectomy, and thus risk endometrial cancer from taking tamoxifen.
Many women are in any case switching to a newer class of drugs known as aromatase inhibitors to treat breast cancer or to the osteoporosis drug raloxifene to prevent it.
Raloxifene, made by Eli Lilly and Co. under the name Evista, has been shown to prevent breast cancer as well as tamoxifen does, without causing as many blood clots, cataracts or as many cases of uterine cancer.
In June, researchers reported that women with breast cancer who switched to Pfizer Inc.'s drug Aromasin after taking tamoxifen were 17 percent less likely to die.
Tamoxifen blocks estrogen, which can help fuel the growth of tumors in some cases.
In women considered at high risk of breast cancer, usually meaning they have a close relative with breast cancer, have had several suspicious-looking lumps, or other conditions, tamoxifen reduced their risk of breast cancer by 49 percent.
Aromasin, known generically as exemestane, and similar drugs inhibit the enzyme aromatase, which is needed to produce estrogen. The aromatase inhibitors are now being used just after breast cancer surgery instead of tamoxifen in many women to keep the disease from returning.
They are not approved for prevention of breast cancer.
Tamoxifen was sold by AstraZeneca Plc under the name Nolvadex but is now marketed by several generic drug makers. It remains the only drug approved for use in preventing breast cancer in women who have not yet reached menopause.
Breast cancer is the second leading cause of cancer death among U.S. women, after lung cancer. More than 200,000 people are diagnosed and another roughly 40,000 die from it each year, according to the American Cancer Society.
